Inspire Medical Systems, Inc. (INSP)
NYSE: INSP · Real-Time Price · USD
149.69
-6.13 (-3.93%)
May 15, 2025, 4:00 PM - Market closed
Inspire Medical Systems Stock Forecast
Stock Price Forecast
According to 12 professional analysts, the 12-month price target for Inspire Medical Systems stock ranges from a low of $174 to a high of $255. The average analyst price target of $213.75 forecasts a 42.80% increase in the stock price over the next year.
Price Target: $213.75 (+42.80%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Inspire Medical Systems stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 2 | 2 |
| Buy | 5 | 5 | 5 | 5 | 6 | 7 |
| Hold | 3 | 3 | 3 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 11 | 11 | 11 | 11 | 11 | 12 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Morgan Stanley | Morgan Stanley | Buy Maintains $220 → $200 | Buy | Maintains | $220 → $200 | +33.61% | May 6, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $235 → $195 | Buy | Maintains | $235 → $195 | +30.27% | May 6, 2025 |
| Wells Fargo | Wells Fargo | Hold Maintains $195 → $174 | Hold | Maintains | $195 → $174 | +16.24% | May 6, 2025 |
| Baird | Baird | Buy Maintains $230 → $236 | Buy | Maintains | $230 → $236 | +57.66% | May 6, 2025 |
| Stifel | Stifel | Hold Maintains $190 → $175 | Hold | Maintains | $190 → $175 | +16.91% | Apr 21, 2025 |
Financial Forecast
Revenue This Year
968.16M
from 802.80M
Increased by 20.60%
Revenue Next Year
1.14B
from 968.16M
Increased by 17.34%
EPS This Year
2.21
from 1.75
Increased by 26.31%
EPS Next Year
3.26
from 2.21
Increased by 47.46%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 1.0B | 1.2B | 1.4B | ||
| Avg | 968.2M | 1.1B | 1.3B | ||
| Low | 921.2M | 1.1B | 1.2B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 24.8% | 23.4% | 24.3% | ||
| Avg | 20.6% | 17.3% | 16.3% | ||
| Low | 14.7% | 10.0% | 6.4% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 2.34 | 4.67 | 6.53 | ||
| Avg | 2.21 | 3.26 | 4.70 | ||
| Low | 2.06 | 2.65 | 3.79 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 33.8% | 111.4% | 100.4% | ||
| Avg | 26.3% | 47.5% | 44.1% | ||
| Low | 17.6% | 19.7% | 16.4% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.